CN105902793A - Traditional Chinese medicine for treatment of coronary heart disease - Google Patents

Traditional Chinese medicine for treatment of coronary heart disease Download PDF

Info

Publication number
CN105902793A
CN105902793A CN201610376001.5A CN201610376001A CN105902793A CN 105902793 A CN105902793 A CN 105902793A CN 201610376001 A CN201610376001 A CN 201610376001A CN 105902793 A CN105902793 A CN 105902793A
Authority
CN
China
Prior art keywords
parts
radix
rhizoma
chinese medicine
semen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610376001.5A
Other languages
Chinese (zh)
Inventor
徐立勇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201610376001.5A priority Critical patent/CN105902793A/en
Publication of CN105902793A publication Critical patent/CN105902793A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/076—Poria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13—Coniferophyta (gymnosperms)
    • A61K36/14—Cupressaceae (Cypress family), e.g. juniper or cypress
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232—Angelica
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/236—Ligusticum (licorice-root)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/284—Atractylodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/286—Carthamus (distaff thistle)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/324—Boswellia, e.g. frankincense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/34—Campanulaceae (Bellflower family)
    • A61K36/344—Codonopsis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/34—Campanulaceae (Bellflower family)
    • A61K36/346—Platycodon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/42—Cucurbitaceae (Cucumber family)
    • A61K36/428—Trichosanthes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481—Astragalus (milkvetch)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/482—Cassia, e.g. golden shower tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484—Glycyrrhiza (licorice)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/486—Millettia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/57—Magnoliaceae (Magnolia family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/79—Schisandraceae (Schisandra family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/884—Alismataceae (Water-plantain family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
    • A61K36/8888—Pinellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/89—Cyperaceae (Sedge family)
    • A61K36/8905—Cyperus (flatsedge)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8965—Asparagus, e.g. garden asparagus or asparagus fern
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8968—Ophiopogon (Lilyturf)

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention provides a traditional Chinese medicine for treatment of coronary heart disease. The traditional Chinese medicine is prepared from the following raw materials by weight: 50-200 parts of panax notoginseng, 50-200 parts of Rhizoma Paridis, 50-200 parts of dragon's blood, 50-200 parts of Salvia Miltiorrhiza, 50-200 parts of Chinese angelica, 50-200 parts of Acorus tatarinowii, 50-200 parts of Codonopsis pilosula, 50-200 parts of Poria cocos, 50-200 parts of Schisandra chinensis, 50-200 parts of ophiopogon japonicas, 50-200 parts of radix asparagi, 50-200 parts of rhizoma corydalis, 50-200 parts of Bidens pilosa, 50-200 parts of Suberect Spatholobus Stem, 50-200 parts of styrax, 50-200 parts of Alisma plantago-aquatica, and 50-200 parts of Allium macrostemon, etc. The traditional Chinese medicine provided by the invention can regulate heart functions, improve cardiac hemodynamic index and increase coronary blood flow, myocardial nutritional blood flow and myocardial blood and oxygen supply, etc., and also can regulate and maintain myocardial oxygen metabolism and energy supply-demand balance, so that ischemic and anoxic myocardium can be improved and protected.

Description

A kind of Chinese medicine treating coronary heart disease
Technical field
The invention belongs to field of medicaments, be specifically related to a kind of Chinese medicine treating coronary heart disease.
Background technology
Coronary heart disease is the abbreviation of coronary atherosclerotic heart disease, refer to supply the blood vessel of cardiotrophin material--there is the most atherosis or spasm in coronary artery, make coronary stricture or blocking, and the obliteration that thrombosis causes, cause a kind of heart disease of myocardial ischemia-anoxemia or infraction, also known as ischemic heart desease.Coronary heart disease is the most common type that atherosclerosis causes organ lesion, is the commonly encountered diseases of harm middle-aged and elderly people health, and presents rejuvenation tendency.
The reason that arteria coronaria narrows is: the blood fat in blood is the most too high, cholesterol accumulates over a long period is deposited on the inner membrance of coronary artery tube chamber, form ground pattern speckle, it is coarse that the inner membrance making otherwise smooth becomes, soft tube wall becomes stiff, on this basis, the platelet ruptured also condenses adhesion up, then just as river course is blocked by mud, make coronary lumen narrow, even entirely shut.Freely even not entirely shutting of arteria coronaria, causes blood supply of cardiac muscle bad, and cardiac muscle can not get the nutrition of blood and necrosis is referred to as myocardial infarction, and this is the performance that coronary heart disease is the most serious.Once cardiac muscle large area infarction, if can not quickly eliminating again, then the life of people the most just finishes.
Modern medicine, under the guidance of this theory, is broadly divided into two classes: one is to use medicine to include expanding blood vessel class medicine and the molten lipid drug of thrombolytic to cardiopathic treatment means；Improve myocardial oxygen delivery and reduce myocardial oxygen consumption, thus alleviating state of an illness symptom.It is typically better during medication, is just returned to the original state of an illness once drug withdrawal, if inappropriate medication, it is also possible to fail to respond to any medical treatment and even increase the weight of disease.Two is support, bypass surgery.In the treatment of coronary heart disease, getting involved operation and bypass surgery broadly falls into invasive treatment, postoperative complication has a strong impact on the healthy of patient simultaneously.These methods particularly significant in the rescue stage to the treatment of cardiac be effective.But the precipitation again that but can not solve the rubbish such as vascular lipids from source forms new speckle, causes blood vessel restenosis, blocking, the problem of the not smooth old sick recurrence of blood supply of cardiac muscle.
The traditional Chinese medical science is thought, the pathogenesis of coronary heart disease is that heart arteries and veins is obstructed, how owing to blood stasis, expectorant are turbid, the stagnation of QI and cause, be again the result of long-term visceral dysfunction, often with heavy meal, catch cold, tired, direct stimulation is as pathogenesis etiology.Cardinal symptom is the squeezing sense of sudden shirtfront or pain, or there is paroxysmal pain at left breastbone rear portion, it is possible to feed through to the positions such as major part pareordia.
Summary of the invention
It is an object of the invention to provide a kind of Chinese medicine treating coronary heart disease, activating blood circulation to dissipate blood stasis, coronary circulation-promoting pain-relieving, be used for treating angina pectoris, make what Coronary Heart Disease Patients thrombosis caused to feel oppressed, the disease such as nervous cardiopalmus that ischemia causes is eliminated.
For reaching above-mentioned technical purpose, the present invention realizes by the following technical solutions:
A kind of Chinese medicine treating coronary heart disease, the raw material including following portions by weight is prepared from: Radix Notoginseng 50-200 part, Rhizoma Paridis 50-200 part, Sanguis Draxonis 50-200 part, Radix Salviae Miltiorrhizae 50-200 part, Radix Angelicae Sinensis 50-200 part, Rhizoma Acori Graminei 50-200 part, Radix Codonopsis 50-200 part；nullPoria 50-200 part、Fructus Schisandrae Chinensis 50-200 part、Radix Ophiopogonis 50-200 part、Radix Asparagi 50-200 part、Semen Platycladi 10-50 part、Radix Platycodonis 10-50 part、Semen Cassiae 20-100 part、Radix Astragali 20-100 part、Os Draconis 20-100 part、Rhizoma Atractylodis Macrocephalae 20-100 part、Rhizoma Chuanxiong 50-200 part、Radix Lamiophlomidis Rotatae 50-200 part、Rhizoma Corydalis 50-200 part、Herba Bidentis Bipinnatae 50-200 part、Caulis Spatholobi 50-200 part、Flos Carthami 20-100 part、Semen Persicae 20-100 part、Styrax 50-200 part、Rhizoma Alismatis 50-200 part、Bulbus Allii Macrostemonis 50-200 part、Fructus Trichosanthis 50-200 part、Rhizoma Pinelliae 50-200 part、Ramulus Cinnamomi 20-100 part、Pollen Typhae 20-100 part、Rhizoma Cyperi 20-100 part、Fructus Aurantii 20-100 part、Radix Glycyrrhizae 20-100 part、Lignum Santali Albi 20-100 part、Olibanum 20-100 part、Myrrha 20-100 part.
Plus-minus symptomatic therapy according to Chinese medicine, according to situations such as the body constitution of patient and diseases, above-mentioned every taste raw material of Chinese medicine can adjust in the number be given, and takes suitable numerical value to reach optimal therapeutic effect.
Further, the raw material including following portions by weight is prepared from: Radix Notoginseng 100 parts, Rhizoma Paridis 100 parts, Sanguis Draxonis 100 parts, Radix Salviae Miltiorrhizae 100 parts, Radix Angelicae Sinensis 1000 parts, Rhizoma Acori Graminei 100 parts, Radix Codonopsis 100 parts；100 parts of Poria, Fructus Schisandrae Chinensis 100 parts, Radix Ophiopogonis 100 parts, Radix Asparagi 100 parts, Semen Platycladi 30 parts, Radix Platycodonis 30 parts, Semen Cassiae 50 parts, the Radix Astragali 50 parts, Os Draconis 50 parts, the Rhizoma Atractylodis Macrocephalae 50 parts, Rhizoma Chuanxiong 100 parts, Radix Lamiophlomidis Rotatae 100 parts, Rhizoma Corydalis 100 parts, Herba Bidentis Bipinnatae 100 parts, Caulis Spatholobi 100 parts, 50 parts of Flos Carthami, 50 parts of Semen Persicae, Styrax 100 parts, Rhizoma Alismatis 100 parts, Bulbus Allii Macrostemonis 100 parts, Fructus Trichosanthis 100 parts, the Rhizoma Pinelliae 100 parts, Ramulus Cinnamomi 100 parts, Pollen Typhae 50 parts, Rhizoma Cyperi 50 parts, Fructus Aurantii 50 parts, 50 parts of Radix Glycyrrhizae, 50 parts of Lignum Santali Albi, Olibanum 50 parts, Myrrha 50 parts.
Further, the raw material including following portions by weight is prepared from: Radix Notoginseng 150 parts, Rhizoma Paridis 150 parts, Sanguis Draxonis 150 parts, Radix Salviae Miltiorrhizae 150 parts, Radix Angelicae Sinensis 150 parts, Rhizoma Acori Graminei 150 parts, Radix Codonopsis 150 parts；150 parts of Poria, Fructus Schisandrae Chinensis 150 parts, Radix Ophiopogonis 150 parts, Radix Asparagi 150 parts, Semen Platycladi 40 parts, Radix Platycodonis 40 parts, Semen Cassiae 60 parts, the Radix Astragali 60 parts, Os Draconis 60 parts, the Rhizoma Atractylodis Macrocephalae 60 parts, Rhizoma Chuanxiong 150 parts, Radix Lamiophlomidis Rotatae 150 parts, Rhizoma Corydalis 150 parts, Herba Bidentis Bipinnatae 150 parts, Caulis Spatholobi 150 parts, 60 parts of Flos Carthami, 60 parts of Semen Persicae, Styrax 150 parts, Rhizoma Alismatis 150 parts, Bulbus Allii Macrostemonis 150 parts, Fructus Trichosanthis 150 parts, the Rhizoma Pinelliae 150 parts, Ramulus Cinnamomi 60 parts, Pollen Typhae 60 parts, Rhizoma Cyperi 60 parts, Fructus Aurantii 60 parts, 60 parts of Radix Glycyrrhizae, 60 parts of Lignum Santali Albi, Olibanum 60 parts, Myrrha 60 parts.
Further, the raw material including following portions by weight is prepared from: Radix Notoginseng 50 parts, Rhizoma Paridis 50 parts, Sanguis Draxonis 50 parts, Radix Salviae Miltiorrhizae 50 parts, Radix Angelicae Sinensis 50 parts, Rhizoma Acori Graminei 50 parts, Radix Codonopsis 50 parts；50 parts of Poria, Fructus Schisandrae Chinensis 50 parts, Radix Ophiopogonis 50 parts, Radix Asparagi 50 parts, Semen Platycladi 10 parts, Radix Platycodonis 10 parts, Semen Cassiae 20 parts, the Radix Astragali 20 parts, Os Draconis 20 parts, the Rhizoma Atractylodis Macrocephalae 20 parts, Rhizoma Chuanxiong 50 parts, Radix Lamiophlomidis Rotatae 50 parts, Rhizoma Corydalis 50 parts, Herba Bidentis Bipinnatae 50 parts, Caulis Spatholobi 50 parts, 20 parts of Flos Carthami, 20 parts of Semen Persicae, Styrax 50 parts, Rhizoma Alismatis 50 parts, Bulbus Allii Macrostemonis 50 parts, Fructus Trichosanthis 50 parts, the Rhizoma Pinelliae 50 parts, Ramulus Cinnamomi 20 parts, Pollen Typhae 20 parts, Rhizoma Cyperi 20 parts, Fructus Aurantii 20 parts, 20 parts of Radix Glycyrrhizae, 20 parts of Lignum Santali Albi, Olibanum 20 parts, Myrrha 20 parts.
Further, the raw material including following portions by weight is prepared from: Radix Notoginseng 180 parts, Rhizoma Paridis 180 parts, Sanguis Draxonis 180 parts, Radix Salviae Miltiorrhizae 180 parts, Radix Angelicae Sinensis 180 parts, Rhizoma Acori Graminei 180 parts, Radix Codonopsis 140 parts；140 parts of Poria, Fructus Schisandrae Chinensis 140 parts, Radix Ophiopogonis 140 parts, Radix Asparagi 140 parts, Semen Platycladi 20 parts, Radix Platycodonis 20 parts, Semen Cassiae 80 parts, the Radix Astragali 80 parts, Os Draconis 80 parts, the Rhizoma Atractylodis Macrocephalae 80 parts, Rhizoma Chuanxiong 140 parts, Radix Lamiophlomidis Rotatae 140 parts, Rhizoma Corydalis 140 parts, Herba Bidentis Bipinnatae 160 parts, Caulis Spatholobi 160 parts, 160 parts of Flos Carthami, 80 parts of Semen Persicae, Styrax 160 parts, Rhizoma Alismatis 160 parts, Bulbus Allii Macrostemonis 160 parts, Fructus Trichosanthis 160 parts, the Rhizoma Pinelliae 160 parts, Ramulus Cinnamomi 80 parts, Pollen Typhae 80 parts, Rhizoma Cyperi 80 parts, Fructus Aurantii 80 parts, 80 parts of Radix Glycyrrhizae, 80 parts of Lignum Santali Albi, Olibanum 80 parts, Myrrha 80 parts.
Further, any one during described Chinese medicine is oral decoction, powder, tablet, capsule.
Raw material pharmacology analysis selected by the present invention:
Effect of Radix Notoginseng: dissipating blood stasis stops blooding, subduing swelling and relieving pain.Effect of Rhizoma Paridis: heat-clearing and toxic substances removing, reducing swelling and alleviating pain, cool liver is calmed the frightened.Effect of Sanguis Draxonis: promoting blood circulation to remove blood stasis, analgesic therapy hemostasis, expelling pus and promoting granulation.Effect of Radix Salviae Miltiorrhizae: blood circulation promoting and blood stasis dispelling, calming heart and tranquilizing mind, evacuation of pus, pain relieving.Effect of Radix Angelicae Sinensis: replenishing and activating blood, menstruction regulating and pain relieving, moisturize laxation.Effect of Rhizoma Acori Graminei: waking up the patient from unconsciousness by dissipating phlegm, removing dampness circulation of qi promoting, profit of dispeling the wind numbness, reducing swelling and alleviating pain.Effect of Radix Codonopsis: invigorating the spleen and replenishing QI, strengthening spleen and tonifying lung.Effect of Poria: promoting diuresis to eliminate damp pathogen, spleen invigorating, calm the nerves.Effect of Fructus Schisandrae Chinensis: astringe the lung, nourishing kidney, promote the production of body fluid, receive antiperspirant, building body.Effect of Radix Ophiopogonis: YIN nourishing and the production of body fluid promoting, lung moistening clears away heart-fire.Effect of Radix Asparagi: replenishing YIN and removing heat, lung moistening nourishing kidney.Effect of Semen Platycladi: tranquilizing by nourishing the heart, arresting sweating, loosening bowel to relieve constipation.Effect of Radix Platycodonis: lung qi dispersing, eliminates the phlegm, sore-throat relieving, evacuation of pus.Effect of Semen Cassiae: clearing away heat to improve acuity of vision, loosening bowel to relieve constipation.Effect of the Radix Astragali: benefiting QI for strengthening the superficies, inducing diuresis to remove edema, detoxification, granulation promoting.Effect of Os Draconis: tranquillizing the mind by relieving convulsion, suppressing the hyperactive liver and subsiding YANG, arresting sweating controlling nocturnal emission with astringent drugs, stop blooding astringing intestine to stop diarrhea, granulation promoting.Effect of the Rhizoma Atractylodis Macrocephalae: air making-up and spleen enlivening, dampness diuretic, hidroschesis, antiabortive.Effect of Rhizoma Chuanxiong: blood-activating and qi-promoting, wind-expelling pain-stopping.Effect of Radix Lamiophlomidis Rotatae: hemostasis and pain-relieving, blood circulation promoting and blood stasis dispelling, inhibiting bacteria and diminishing inflammation, improves immunity.Effect of Rhizoma Corydalis: regulating QI to relieve pain, promoting blood circulation to remove blood stasis.Effect of Herba Bidentis Bipinnatae: heat clearing away, removing toxic substances, dissipating blood stasis, detumescence.Effect of Caulis Spatholobi: relaxing muscles and tendons to promote blood circulation, nourishing blood for regulating menstruation.Effect of Flos Carthami: latus rectum of invigorating blood circulation, eliminating stasis to stop pain.Effect of Semen Persicae: promoting blood circulation to restore menstrual flow, dispelling phlegm and alleviating pain.Effect of Styrax: refreshment of having one's ideas straightened out, wards off dirty pain relieving.Effect of Rhizoma Alismatis: promoting diuresis to eliminate damp pathogen, expels the heat-evil, and changes turbid blood fat reducing.Effect of Bulbus Allii Macrostemonis: the chest stuffiness relieving of regulating the flow of vital energy, activating YANG and eliminating stagnation.Effect of Fructus Trichosanthis: lung moistening is dry, pathogenic fire reducing, control cough, clearing away phlegm is tied, throat, profit large intestine, subduing inflammation sore.Effect of the Rhizoma Pinelliae: drying dampness to eliminate phlegm, stopping nausea and vomiting by lowering the adverse flow of QI, dissolving lump and resolving mass.Effect of Ramulus Cinnamomi: relieving the exterior syndrome with drugs of pungent in flavor and warm in nature, expelling pathogenic factors from muscles delivers, harmonizing yingfen and weifen.Effect of Pollen Typhae: analgesia, anticoagulant coagulant (relevant with concentration), blood circulation promoting, reduces blood fat, prevents arteriosclerosis, protection vascular endothelial injury caused by hyperlipemia, enhancing immunity.Effect of Rhizoma Cyperi: resolving depression of regulating the flow of vital energy, pain relieving regulating menstruation.Effect of Fructus Aurantii: dispelling the stagnated QI, row expectorant, removing food stagnancy.Effect of Radix Glycyrrhizae: invigorating the spleen and replenishing QI, nourishing the lung to arrest cough, eliminating fire and detoxication, relieving spasm to stop pain, coordinating the actions of various ingredients in a prescription.Effect of Lignum Santali Albi: promoting the circulation of QI to relieve pain, during cold expelling is adjusted, purify the blood antiinflammatory, pacifies nervous and anxiety.Effect of Olibanum: blood-activating and qi-promoting, inducing menstruation to relieve menalgia, detumescence and promoting granulation.
The diseases such as the compatibility of raw material of the present invention is unique rationally, it is possible to adjusts the imbalance between YIN and YANG of whole body, activating blood circulation to dissipate blood stasis, coronary circulation-promoting pain-relieving, is used for treating angina pectoris, makes what Coronary Heart Disease Patients thrombosis caused to feel oppressed, the nervous cardiopalmus that ischemia causes are eliminated；It is obviously improved the blood supply of patient, improves blood supply oxygen delivery capacity in the patient, play effect of dredge the meridian passage, activating blood circulation to dissipate blood stasis, heat-clearing and toxic substances removing, Repercusion analgesia.This Chinese medicine existing regulation cardiac function, improves cardiac hemodynamic index and increases the effects such as coronary flow, myocardial alimentary blood flow and cardiac muscle blood oxygen supply；Can regulate and maintain again the equilibrium of supply and demand of Myocardial Oxygen Metabolism and energy, make ischemia obtain improving and protection with the cardiac muscle of anoxia.
Utilizing conventional method prepared by Chinese medicine, the present invention treats the Chinese medicine of coronary heart disease can make decocting decoction, electuary, pill, tablet or capsule etc..
The curative effect of Chinese medicine of the present invention is described below by clinical data:
1, clinical observation
Patient 220 people of coronary heart disease accepted from 2005 to 2015 years and follows the tracks of altogether for medical treatment by Chinese medicine of the present invention, and wherein the age is 10 examples of 30 ~ 40 years old, and the age is 30 examples of 40 ~ 50 years old, 180 examples of more than 50 years old, and M-F is 1:1.
2, Therapeutic Method
Instructions of taking: use the electuary that Chinese medicine of the present invention is made, patient the most once, typically need to take one to three courses for the treatment of, and each course for the treatment of is three months.Other drug is disabled during treatment.Patient does relevant inspection itemized record the most afterwards.
Dietetic contraindication: simultaneously should not take with other Chinese medicine when taking, aviod certain food wine, maror.
3, criterion of therapeutical effect:
Notable: after drug administration, physical recovery；And check after drug withdrawal half a year, without recurrence.
Effective: after drug administration, sb.'s illness took a favorable turn substantially.
Invalid: without improving before relatively taking after drug administration.
4, efficacy result:
　 Total number of persons Notable number Efficiently individual quantity Invalid number Effective percentage
The present invention 220 80 110 30 86%
5, some cases data:
Case 1, Dezhou, Mrs Wang, 53 years old, in May, 2006 found coronary heart disease in hospital, and has made cardiac stent operation；Post operation is weak all over, both feet edema.After taking the present invention 3 months, health is substantially achieved recovery, can go to work in the fields；So far health is good.
Case 2, Yanbian, Jilin Province, Mr. Lin, 73 years old, suffer from coronary heart disease for many years, within 2012, conditions of patients is serious, and green around the gills is weak all over, sensation of oppression over the chest with shortness of breath；Starting to take Chinese medicine of the present invention in JIUYUE, 2012, after taking 3 months continuously, symptom gradually alleviates until disappearing.
Case 3, Beijing, Mr. Xie, 40 years old, because of insobriety in one's early years, cause systemic disease especially heart, liver damage serious.In May, 2013 goes on business in Qingdao, and burst heart infarction is in hospital, edema from head to foot, and cardiopalmus is breathed hard, weak, insomnia, and dreaminess is dizzy.After 3 doses of hair Chinese medicine of the present invention, total urination time increases, and edema and cardio-pulmonary function are improved；After continuing again to take 6 months, symptom eliminates.
Case 4, Qingdao, Mr. Guo, 64 years old, in April, 2014 fell ill, and is coronary heart disease through hospital diagnosis, and goes to Beijing to do bypass surgery；After surgery, patient pulse is faint, complexion is greyish white, gatism, urinary tract infection, bed anorexia.After taking said medicine 1 month, symptom alleviates；After taking 9 months continuously, symptom is wholly absent；So far do not recur again.
Case 5, Qingdao, Mrs Wang, 34 years old, the most repeatedly feels cardiopalmus, uncomfortable in chest, paroxysmal stabbing pain over the chest for 2010, sometimes occurs that heart beating is accelerated suddenly, arrhythmia, hospital diagnosis is coronary heart disease.After taking this Chinese medicine continuously 3 months, above-mentioned symptom progressively alleviates disappearance；Check indices is normal.So far health is good without recurrence.
Case 6, Huang Island, Mr. Zong, 58 years old, to suffer from hypertension for many years, within 2013, made a definite diagnosis by hospital and develop into rheumatic heart disease, coronary heart disease, cardinal symptom is；Dyspnea, vexed swollen, breathe hard, weak, meet cool aggravation.In JIUYUE, 2013 starts to take Chinese medicine of the present invention, and after taking 6 months continuously, symptom disappears substantially；Electrocardiogram check has recovered normal.
6, clinical analysis
Chinese medicine clinical verification satisfactory effect of the present invention, can improve the immunologic function of body, regulates body equilibrium between yin and yang, activating blood circulation to dissipate blood stasis, coronary circulation-promoting pain-relieving, it is used for treating angina pectoris, making what Coronary Heart Disease Patients thrombosis caused to feel oppressed, the disease such as nervous cardiopalmus that ischemia causes is eliminated；The Chinese medicine of the present invention is applicable to effective treatment of coronary heart disease, and without obvious side effect, after patient on medication, to routine examinations such as the hepatic and renal function of patient, routine blood test, defecation, all not finding the ANOMALOUS VARIATIONS caused because taking Chinese medicine of the present invention, clinic is promoted the use of.
Detailed description of the invention
In order to be better understood from and implement the present invention, further illustrate below in conjunction with embodiment.
Embodiment 1:
A kind of Chinese medicine treating coronary heart disease, is to be prepared from by the raw material of following portions by weight: Radix Notoginseng 100 parts, Rhizoma Paridis 100 parts, Sanguis Draxonis 100 parts, Radix Salviae Miltiorrhizae 100 parts, Radix Angelicae Sinensis 1000 parts, Rhizoma Acori Graminei 100 parts, Radix Codonopsis 100 parts；100 parts of Poria, Fructus Schisandrae Chinensis 100 parts, Radix Ophiopogonis 100 parts, Radix Asparagi 100 parts, Semen Platycladi 30 parts, Radix Platycodonis 30 parts, Semen Cassiae 50 parts, the Radix Astragali 50 parts, Os Draconis 50 parts, the Rhizoma Atractylodis Macrocephalae 50 parts, Rhizoma Chuanxiong 100 parts, Radix Lamiophlomidis Rotatae 100 parts, Rhizoma Corydalis 100 parts, Herba Bidentis Bipinnatae 100 parts, Caulis Spatholobi 100 parts, 50 parts of Flos Carthami, 50 parts of Semen Persicae, Styrax 100 parts, Rhizoma Alismatis 100 parts, Bulbus Allii Macrostemonis 100 parts, Fructus Trichosanthis 100 parts, the Rhizoma Pinelliae 100 parts, Ramulus Cinnamomi 100 parts, Pollen Typhae 50 parts, Rhizoma Cyperi 50 parts, Fructus Aurantii 50 parts, 50 parts of Radix Glycyrrhizae, 50 parts of Lignum Santali Albi, Olibanum 50 parts, Myrrha 50 parts.
Above-mentioned each single raw material pulverizer is crushed to 100-200 mesh, then according to aforementioned proportion takes each raw material after pulverizing, is sufficiently mixed the Powdered electuary of system；Or powder is pressed into tablet, or powder is loaded capsule makes capsule.
Embodiment 2:
A kind of Chinese medicine treating coronary heart disease, is to be prepared from by the raw material of following portions by weight: Radix Notoginseng 150 parts, Rhizoma Paridis 150 parts, Sanguis Draxonis 150 parts, Radix Salviae Miltiorrhizae 150 parts, Radix Angelicae Sinensis 150 parts, Rhizoma Acori Graminei 150 parts, Radix Codonopsis 150 parts；150 parts of Poria, Fructus Schisandrae Chinensis 150 parts, Radix Ophiopogonis 150 parts, Radix Asparagi 150 parts, Semen Platycladi 40 parts, Radix Platycodonis 40 parts, Semen Cassiae 60 parts, the Radix Astragali 60 parts, Os Draconis 60 parts, the Rhizoma Atractylodis Macrocephalae 60 parts, Rhizoma Chuanxiong 150 parts, Radix Lamiophlomidis Rotatae 150 parts, Rhizoma Corydalis 150 parts, Herba Bidentis Bipinnatae 150 parts, Caulis Spatholobi 150 parts, 60 parts of Flos Carthami, 60 parts of Semen Persicae, Styrax 150 parts, Rhizoma Alismatis 150 parts, Bulbus Allii Macrostemonis 150 parts, Fructus Trichosanthis 150 parts, the Rhizoma Pinelliae 150 parts, Ramulus Cinnamomi 60 parts, Pollen Typhae 60 parts, Rhizoma Cyperi 60 parts, Fructus Aurantii 60 parts, 60 parts of Radix Glycyrrhizae, 60 parts of Lignum Santali Albi, Olibanum 60 parts, Myrrha 60 parts.
Above-mentioned each single raw material pulverizer is crushed to 150-180 mesh, then according to aforementioned proportion takes each raw material after pulverizing, is sufficiently mixed and makes capsule.
Embodiment 3:
A kind of Chinese medicine treating coronary heart disease, is to be prepared from by the raw material of following portions by weight: Radix Notoginseng 180 parts, Rhizoma Paridis 180 parts, Sanguis Draxonis 180 parts, Radix Salviae Miltiorrhizae 180 parts, Radix Angelicae Sinensis 180 parts, Rhizoma Acori Graminei 180 parts, Radix Codonopsis 140 parts；140 parts of Poria, Fructus Schisandrae Chinensis 140 parts, Radix Ophiopogonis 140 parts, Radix Asparagi 140 parts, Semen Platycladi 20 parts, Radix Platycodonis 20 parts, Semen Cassiae 80 parts, the Radix Astragali 80 parts, Os Draconis 80 parts, the Rhizoma Atractylodis Macrocephalae 80 parts, Rhizoma Chuanxiong 140 parts, Radix Lamiophlomidis Rotatae 140 parts, Rhizoma Corydalis 140 parts, Herba Bidentis Bipinnatae 160 parts, Caulis Spatholobi 160 parts, 160 parts of Flos Carthami, 80 parts of Semen Persicae, Styrax 160 parts, Rhizoma Alismatis 160 parts, Bulbus Allii Macrostemonis 160 parts, Fructus Trichosanthis 160 parts, the Rhizoma Pinelliae 160 parts, Ramulus Cinnamomi 80 parts, Pollen Typhae 80 parts, Rhizoma Cyperi 80 parts, Fructus Aurantii 80 parts, 80 parts of Radix Glycyrrhizae, 80 parts of Lignum Santali Albi, Olibanum 80 parts, Myrrha 80 parts.
Above-mentioned each single raw material pulverizer is crushed to 120 mesh, then according to aforementioned proportion takes each raw material after pulverizing, is sufficiently mixed the Powdered electuary of system.

Claims (6)

1. the Chinese medicine treating coronary heart disease, it is characterized in that, the raw material including following portions by weight is prepared from: Radix Notoginseng 50-200 part, Rhizoma Paridis 50-200 part, Sanguis Draxonis 50-200 part, Radix Salviae Miltiorrhizae 50-200 part, Radix Angelicae Sinensis 50-200 part, Rhizoma Acori Graminei 50-200 part, Radix Codonopsis 50-200 part；nullPoria 50-200 part、Fructus Schisandrae Chinensis 50-200 part、Radix Ophiopogonis 50-200 part、Radix Asparagi 50-200 part、Semen Platycladi 10-50 part、Radix Platycodonis 10-50 part、Semen Cassiae 20-100 part、Radix Astragali 20-100 part、Os Draconis 20-100 part、Rhizoma Atractylodis Macrocephalae 20-100 part、Rhizoma Chuanxiong 50-200 part、Radix Lamiophlomidis Rotatae 50-200 part、Rhizoma Corydalis 50-200 part、Herba Bidentis Bipinnatae 50-200 part、Caulis Spatholobi 50-200 part、Flos Carthami 20-100 part、Semen Persicae 20-100 part、Styrax 50-200 part、Rhizoma Alismatis 50-200 part、Bulbus Allii Macrostemonis 50-200 part、Fructus Trichosanthis 50-200 part、Rhizoma Pinelliae 50-200 part、Ramulus Cinnamomi 20-100 part、Pollen Typhae 20-100 part、Rhizoma Cyperi 20-100 part、Fructus Aurantii 20-100 part、Radix Glycyrrhizae 20-100 part、Lignum Santali Albi 20-100 part、Olibanum 20-100 part、Myrrha 20-100 part.
Chinese medicine the most according to claim 1, it is characterised in that include that the raw material of following portions by weight is prepared from: Radix Notoginseng 100 parts, Rhizoma Paridis 100 parts, Sanguis Draxonis 100 parts, Radix Salviae Miltiorrhizae 100 parts, Radix Angelicae Sinensis 1000 parts, Rhizoma Acori Graminei 100 parts, Radix Codonopsis 100 parts；100 parts of Poria, Fructus Schisandrae Chinensis 100 parts, Radix Ophiopogonis 100 parts, Radix Asparagi 100 parts, Semen Platycladi 30 parts, Radix Platycodonis 30 parts, Semen Cassiae 50 parts, the Radix Astragali 50 parts, Os Draconis 50 parts, the Rhizoma Atractylodis Macrocephalae 50 parts, Rhizoma Chuanxiong 100 parts, Radix Lamiophlomidis Rotatae 100 parts, Rhizoma Corydalis 100 parts, Herba Bidentis Bipinnatae 100 parts, Caulis Spatholobi 100 parts, 50 parts of Flos Carthami, 50 parts of Semen Persicae, Styrax 100 parts, Rhizoma Alismatis 100 parts, Bulbus Allii Macrostemonis 100 parts, Fructus Trichosanthis 100 parts, the Rhizoma Pinelliae 100 parts, Ramulus Cinnamomi 100 parts, Pollen Typhae 50 parts, Rhizoma Cyperi 50 parts, Fructus Aurantii 50 parts, 50 parts of Radix Glycyrrhizae, 50 parts of Lignum Santali Albi, Olibanum 50 parts, Myrrha 50 parts.
Chinese medicine the most according to claim 1, it is characterised in that include that the raw material of following portions by weight is prepared from: Radix Notoginseng 150 parts, Rhizoma Paridis 150 parts, Sanguis Draxonis 150 parts, Radix Salviae Miltiorrhizae 150 parts, Radix Angelicae Sinensis 150 parts, Rhizoma Acori Graminei 150 parts, Radix Codonopsis 150 parts；150 parts of Poria, Fructus Schisandrae Chinensis 150 parts, Radix Ophiopogonis 150 parts, Radix Asparagi 150 parts, Semen Platycladi 40 parts, Radix Platycodonis 40 parts, Semen Cassiae 60 parts, the Radix Astragali 60 parts, Os Draconis 60 parts, the Rhizoma Atractylodis Macrocephalae 60 parts, Rhizoma Chuanxiong 150 parts, Radix Lamiophlomidis Rotatae 150 parts, Rhizoma Corydalis 150 parts, Herba Bidentis Bipinnatae 150 parts, Caulis Spatholobi 150 parts, 60 parts of Flos Carthami, 60 parts of Semen Persicae, Styrax 150 parts, Rhizoma Alismatis 150 parts, Bulbus Allii Macrostemonis 150 parts, Fructus Trichosanthis 150 parts, the Rhizoma Pinelliae 150 parts, Ramulus Cinnamomi 60 parts, Pollen Typhae 60 parts, Rhizoma Cyperi 60 parts, Fructus Aurantii 60 parts, 60 parts of Radix Glycyrrhizae, 60 parts of Lignum Santali Albi, Olibanum 60 parts, Myrrha 60 parts.
Chinese medicine the most according to claim 1, it is characterised in that include that the raw material of following portions by weight is prepared from: Radix Notoginseng 50 parts, Rhizoma Paridis 50 parts, Sanguis Draxonis 50 parts, Radix Salviae Miltiorrhizae 50 parts, Radix Angelicae Sinensis 50 parts, Rhizoma Acori Graminei 50 parts, Radix Codonopsis 50 parts；50 parts of Poria, Fructus Schisandrae Chinensis 50 parts, Radix Ophiopogonis 50 parts, Radix Asparagi 50 parts, Semen Platycladi 10 parts, Radix Platycodonis 10 parts, Semen Cassiae 20 parts, the Radix Astragali 20 parts, Os Draconis 20 parts, the Rhizoma Atractylodis Macrocephalae 20 parts, Rhizoma Chuanxiong 50 parts, Radix Lamiophlomidis Rotatae 50 parts, Rhizoma Corydalis 50 parts, Herba Bidentis Bipinnatae 50 parts, Caulis Spatholobi 50 parts, 20 parts of Flos Carthami, 20 parts of Semen Persicae, Styrax 50 parts, Rhizoma Alismatis 50 parts, Bulbus Allii Macrostemonis 50 parts, Fructus Trichosanthis 50 parts, the Rhizoma Pinelliae 50 parts, Ramulus Cinnamomi 20 parts, Pollen Typhae 20 parts, Rhizoma Cyperi 20 parts, Fructus Aurantii 20 parts, 20 parts of Radix Glycyrrhizae, 20 parts of Lignum Santali Albi, Olibanum 20 parts, Myrrha 20 parts.
Chinese medicine the most according to claim 1, it is characterised in that include that the raw material of following portions by weight is prepared from: Radix Notoginseng 180 parts, Rhizoma Paridis 180 parts, Sanguis Draxonis 180 parts, Radix Salviae Miltiorrhizae 180 parts, Radix Angelicae Sinensis 180 parts, Rhizoma Acori Graminei 180 parts, Radix Codonopsis 140 parts；140 parts of Poria, Fructus Schisandrae Chinensis 140 parts, Radix Ophiopogonis 140 parts, Radix Asparagi 140 parts, Semen Platycladi 20 parts, Radix Platycodonis 20 parts, Semen Cassiae 80 parts, the Radix Astragali 80 parts, Os Draconis 80 parts, the Rhizoma Atractylodis Macrocephalae 80 parts, Rhizoma Chuanxiong 140 parts, Radix Lamiophlomidis Rotatae 140 parts, Rhizoma Corydalis 140 parts, Herba Bidentis Bipinnatae 160 parts, Caulis Spatholobi 160 parts, 160 parts of Flos Carthami, 80 parts of Semen Persicae, Styrax 160 parts, Rhizoma Alismatis 160 parts, Bulbus Allii Macrostemonis 160 parts, Fructus Trichosanthis 160 parts, the Rhizoma Pinelliae 160 parts, Ramulus Cinnamomi 80 parts, Pollen Typhae 80 parts, Rhizoma Cyperi 80 parts, Fructus Aurantii 80 parts, 80 parts of Radix Glycyrrhizae, 80 parts of Lignum Santali Albi, Olibanum 80 parts, Myrrha 80 parts.
6. according to the Chinese medicine described in any one of claim 1 to 5, it is characterised in that described Chinese medicine is any one in oral decoction, powder, tablet, capsule.
CN201610376001.5A 2016-05-31 2016-05-31 Traditional Chinese medicine for treatment of coronary heart disease Pending CN105902793A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610376001.5A CN105902793A (en) 2016-05-31 2016-05-31 Traditional Chinese medicine for treatment of coronary heart disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610376001.5A CN105902793A (en) 2016-05-31 2016-05-31 Traditional Chinese medicine for treatment of coronary heart disease

Publications (1)

Publication Number Publication Date
CN105902793A true CN105902793A (en) 2016-08-31

Family

ID=56742788

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610376001.5A Pending CN105902793A (en) 2016-05-31 2016-05-31 Traditional Chinese medicine for treatment of coronary heart disease

Country Status (1)

Country Link
CN (1) CN105902793A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109078146A (en) * 2018-09-04 2018-12-25 陈旭华 A kind of heart disease maintenance external application Chinese medicine ointment preparation, traditional Chinese medicinal ointment and purposes
CN113786471A (en) * 2021-09-10 2021-12-14 北京生万生物医药科技有限公司 Traditional Chinese medicine composition for treating cardiac pain
CN115737731A (en) * 2022-11-30 2023-03-07 陕西东泰制药有限公司 A Chinese medicinal composition for promoting blood circulation, removing blood stasis, and dredging meridian passage, and its preparation method

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1546067A (en) * 2003-09-15 2004-11-17 史 忠 Chinese traditional medicine for treating coronary disease and angina
CN101698090A (en) * 2009-11-19 2010-04-28 泰一和浦（北京）中医药研究院有限公司 Traditional Chinese medicine composite for treating coma and heart syncope symptoms and preparation method thereof
CN104225531A (en) * 2014-09-12 2014-12-24 王园园 Traditional Chinese medicine for treating coronary heart disease
CN104740289A (en) * 2013-12-26 2015-07-01 曹红云 Traditional Chinese medicine for treating coronary heart disease

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1546067A (en) * 2003-09-15 2004-11-17 史 忠 Chinese traditional medicine for treating coronary disease and angina
CN101698090A (en) * 2009-11-19 2010-04-28 泰一和浦（北京）中医药研究院有限公司 Traditional Chinese medicine composite for treating coma and heart syncope symptoms and preparation method thereof
CN104740289A (en) * 2013-12-26 2015-07-01 曹红云 Traditional Chinese medicine for treating coronary heart disease
CN104225531A (en) * 2014-09-12 2014-12-24 王园园 Traditional Chinese medicine for treating coronary heart disease

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109078146A (en) * 2018-09-04 2018-12-25 陈旭华 A kind of heart disease maintenance external application Chinese medicine ointment preparation, traditional Chinese medicinal ointment and purposes
CN113786471A (en) * 2021-09-10 2021-12-14 北京生万生物医药科技有限公司 Traditional Chinese medicine composition for treating cardiac pain
CN115737731A (en) * 2022-11-30 2023-03-07 陕西东泰制药有限公司 A Chinese medicinal composition for promoting blood circulation, removing blood stasis, and dredging meridian passage, and its preparation method
CN115737731B (en) * 2022-11-30 2024-03-08 陕西东泰制药有限公司 A Chinese medicinal composition for promoting blood circulation, removing blood stasis, dredging meridian passage, and its preparation method

Similar Documents

Publication Publication Date Title
CN1302805C (en) Ready prepared Chinese medicine for preventing and treating brain apoplexia
CN104383363A (en) Traditional Chinese medicinal composition for treating gout
CN103520572A (en) Traditional Chinese composition used for treating atopic dermatitis as well as preparation method of composition
CN102210820A (en) Chinese medicinal composition for treating leukemia
CN104383115A (en) Traditional Chinese medicine preparation for treating coronary heart disease and preparation method of traditional Chinese medicine preparation
CN104013868B (en) Traditional Chinese medicine composition for treating chronic obstructive pulmonary disease and preparation method thereof
CN103006842B (en) Drug for treatment of traditional Chinese medicine chest stuffiness and pains
CN102988904B (en) Drug for removing gall stone
CN105902793A (en) Traditional Chinese medicine for treatment of coronary heart disease
CN104324340B (en) It is a kind of to treat Chinese medicine preparation of heel bone hyperosteogeny and preparation method thereof
CN100512852C (en) Composite Chinese medicine took orally for treating coronary heart disease
CN102488875A (en) Traditional Chinese medicine for treating acquired dysmenorrhea
CN104000890B (en) Traditional Chinese medicine for harmonizing liver and spleen, dispelling wind and eliminating dampness and nourishing blood and stopping throat pains
CN103690869B (en) Chinese medicine for the treatment of irritable bowel syndrome and preparation method thereof
CN105126034A (en) Pharmaceutical preparation for treating coronary heart disease
CN105456924A (en) Traditional Chinese medicine preparation containing Folium Artemisiae Argyi and having functions of promoting circulation and removing stasis and preparation method thereof
CN104958677A (en) Traditional Chinese medicine preparation for treating membranous nephropathy and preparation method of traditional Chinese medicine preparation
CN104888133A (en) Traditional Chinese medicine composition for treatment of coronary heart disease
CN104721802A (en) TCM (traditional Chinese medicine) preparation for treating constrictive pericarditis and preparing method thereof
CN104189714A (en) Traditional Chinese medicine capsule for treating coronary heart disease
CN102357210B (en) Traditional Chinese medicine composition for curing facial acne
CN104491830A (en) Traditional Chinese medicine composition for preventing and controlling tuberculosis and preparation method thereof
CN105709005A (en) Breast rehabilitation promoting pill
CN104758888A (en) Traditional Chinese medicine composition for treating diabetes
CN104524535A (en) Traditional Chinese medicine composition for treating chronic pulmonary heart disease and preparation method of traditional Chinese medicine composition

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20160831

RJ01 Rejection of invention patent application after publication